Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

genus pharmaceuticals ltd - atomoxetine hydrochloride - oral capsule - 10mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

macleods pharma uk ltd - atomoxetine hydrochloride - oral capsule - 10mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

glenmark pharmaceuticals europe ltd - atomoxetine hydrochloride - oral capsule - 10mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - atomoxetine hydrochloride - oral capsule - 10mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

neuraxpharm uk ltd - atomoxetine hydrochloride - oral capsule - 10mg

Estats Units - anglès - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - atomoxetine hydrochloride (unii: 57wvb6i2w0) (atomoxetine - unii:asw034s0b8) - atomoxetine hydrochloride 25 mg - strattera is indicated for the treatment of attention-deficit/hyperactivity disorder (adhd). the efficacy of strattera capsules was established in seven clinical trials in outpatients with adhd: four 6 to 9-week trials in pediatric patients (ages 6 to 18), two 10-week trial in adults, and one maintenance trial in pediatrics (ages 6 to 15) [see clinical studies (14)]. a diagnosis of adhd (dsm-iv) implies the presence of hyperactive-impulsive or inattentive symptoms that cause impairment and that were present before age 7 years. the symptoms must be persistent, must be more severe than is typically observed in individuals at a comparable level of development, must cause clinically significant impairment, e.g., in social, academic, or occupational functioning, and must be present in 2 or more settings, e.g., school (or work) and at home. the symptoms must not be better accounted for by another mental disorder. the specific etiology of adhd is unknown, and there is no single diagnostic test. adequate

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - atomoxetine hydrochloride -

Egipte - anglès - EDA (Egyptian Drug Authority)

eli lilly-egypt - capsule - 10 mg